Weekly feed

Week of Oct 18–24, 2026

15 curated updates · reviewed against primary sources

Archive
All Open for comment ONC/ASTP CMS HL7 FHIR HITRUST FDA
High CMS

CMS proposes allowing payers to use ONC-adopted API standards updates without new rulemaking

CMS’s 2026 proposed rule would let payers automatically use newer versions of required FHIR and USCDI standards as ONC approves them, reducing the need for frequent CMS rule changes. CMS released a CMS.gov resource page outlining the API and standards requirements stemming from the 2020...

High FDA 💬 Comments close in 22 days (Nov 24)

FDA Issues Draft Guidance on Pre-Market Testing for Surgical Robot Systems

FDA's new draft guidance expands pre-market testing requirements for robotic-assisted surgical devices to include cybersecurity, human factors, and operating room integration, with comments due November 24. The FDA has published draft guidance on pre-market testing for robotically-assisted...

Notable FDA 💬 Comments close in 7 days (Nov 9)

FDA Seeks OMB Clearance for Medical Device Adverse Event Reporting Program (MedSun)

FDA's submission of the MedSun information collection for OMB review signals continued focus on post-market surveillance of medical devices through structured adverse event reporting. The Food and Drug Administration has submitted a proposed information collection request to the Office of...

Notable FDA HHS 💬 Comments close in 18 days (Nov 20)

FDA Requests Input on Ibogaine Clinical Trial Design for Opioid Use Disorder and PTSD

FDA seeks public comments on safety and design elements for early-phase ibogaine trials as HHS-funded studies in opioid use disorder and PTSD prepare to launch. The FDA is issuing a Request for Information (RFI) to gather public input on the design and safety considerations for early-phase...

Notable HHS 💬 Comments close in 2 days (Nov 4)

AHRQ Seeks OMB Approval for Revised CAHPS Database for Health Plans Collection

AHRQ requests public comment on a proposed revision to its CAHPS Database for Health Plans information collection, with the comment period closing November 4, 2026. The Agency for Healthcare Research and Quality (AHRQ) has announced its intention to request Office of Management and Budget (OMB)...

Notable FDA 💬 Comments close in 11 days (Nov 13)

FDA Seeks Public Input on Statistical Design of Rare Disease Clinical Trials

FDA is opening a public docket to gather comments on statistical methods for rare disease clinical investigations ahead of a RISE workshop to inform future guidance. The FDA has established a public docket (2026-18805) to collect comments on statistical considerations for the design of rare...

Notable HHS 💬 Comment window closed

NIH Proposes Updated Biosafety Policy for Biohazard Research

NIH seeks public comment on draft policy to modernize biosafety oversight for recombinant and synthetic nucleic acid research. The National Institutes of Health (NIH) has published a draft biosafety policy for research involving biohazards in the Federal Register, proposing to modernize and...